V. Ricci

发表

Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients.

C. Caltagirone, A. Bentivoglio, P. Bria, 2010, Journal of clinical psychopharmacology.

Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.

Carlo Caltagirone, Gianfranco Spalletta, Francesco Angelucci, 2009, International review of neurobiology.

CLINICAL STUDY: BRIEF REPORT: Ecstasy (MDMA)‐addicted subjects show increased serum levels of brain‐derived neurotrophic factor, independently from a rise of drug‐induced psychotic symptoms

C. Caltagirone, G. Spalletta, P. Bria, 2010, Addiction biology.

Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor

P. Bria, F. Angelucci, M. Pomponi, 2007 .

Neuroprotective Effect of Neuropeptide Y against Beta-Amyloid 25–35 Toxicity in SH-SY5Y Neuroblastoma Cells Is Associated with Increased Neurotrophin Production

C. Caltagirone, F. Angelucci, G. Federici, 2011, Neurodegenerative Diseases.

Enhanced BDNF serum levels in patients with severe pathological gambling

C. Caltagirone, P. Bria, G. Martinotti, 2013, Addiction Biology.

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms

G. Biggio, G. Martinotti, A. Valchera, 2016, The international journal of neuropsychopharmacology.

Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report

G. Maina, V. Ricci, Gabriele Di Salvo, 2021, Journal of addictive diseases.

Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia

A. Fagiolini, G. Martinotti, G. Maina, 2023, Journal of clinical psychopharmacology.

Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report

G. Martinotti, G. Maina, D. de Berardis, 2022, International journal of environmental research and public health.

GABAA receptor subtype specific enhancement of inhibition in human motor cortex

Federico Ranieri, Vincenzo Di Lazzaro, Ulf Ziemann, 2006, The Journal of physiology.

Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.

G. Martinotti, G. Di Iorio, M. Di Giannantonio, 2012, Journal of biological regulators and homeostatic agents.

Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers

C. Caltagirone, G. Spalletta, P. Bria, 2008, European Neuropsychopharmacology.

BDNF concentration and impulsiveness level in post-traumatic stress disorder

Carlo Caltagirone, Francesco Gambi, Gianna Sepede, 2015, Psychiatry Research.

BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure

Carlo Caltagirone, Gianna Sepede, Giovanni Martinotti, 2014, Brain and Cognition.

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

C. Caltagirone, P. Bria, G. Martinotti, 2011, Psychopharmacology.

Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation.

P. Pasqualetti, P. Bria, V. Di Lazzaro, 2011, Journal of neurophysiology.

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms

G. Martinotti, M. Di Giannantonio, G. Maina, 2021, International journal of environmental research and public health.

Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.

G. Martinotti, A. Salone, S. Fraticelli, 2021, Drug and alcohol dependence.

Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: A TMS study

P. Bria, U. Ziemann, P. Tonali, 2007, Clinical Neurophysiology.

Internet Gaming Disorders and Early Onset Psychosis in Young People: A Case Study and Clinical Observations

G. Martinotti, G. Maina, D. de Berardis, 2023, International journal of environmental research and public health.

Heautoscopic hallucinations in first episode psychosis: report of one case and clinical overview

G. Maina, D. de Berardis, V. Ricci, 2023, Psychosis.

In response to: AMPA receptor potentially participates in the mediation of the increased brain-derived neurotrophic factor following chronic ketamine use by Yang, Jianjun; Zhou, Zhiqiang; Yang, Chun

C. Caltagirone, F. Angelucci, V. Ricci, 2012, Psychopharmacology.

Brain-Derived Neurotrophic Factor and Electroconvulsive Therapy in a Schizophrenic Patient With Treatment-Resistant Paranoid-Hallucinatory Symptoms

C. Caltagirone, P. Bria, G. Martinotti, 2011, The journal of ECT.

Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: A case report

C. Caltagirone, P. Bria, G. Martinotti, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Neuroprotective Effect of Neuropeptide Y against Beta-Amyloid 25–35 Toxicity in SH-SY5Y Neuroblastoma Cells Is Associated with Increased Neurotrophin Production

C. Caltagirone, F. Angelucci, G. Federici, 2011, Neurodegenerative Diseases.

different protocols of stimulation rTMS: comparison of local and remote effects of six Modulation of motor cortex neuronal networks by

P. Pasqualetti, J. Rothwell, N. Murase, 2015 .

BDNF concentration and impulsiveness level in post-traumatic stress disorder

C. Caltagirone, G. Martinotti, F. Angelucci, 2015, Psychiatry Research.

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

T. Schneider-Axmann, R. Jardri, T. Wobrock, 2023, EClinicalMedicine.

Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview.

V. Ricci, Giovanni Martinotti, Giuseppe Maina, 2023, Psychopathology.

P0048 - Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor

P. Bria, F. Angelucci, M. Pomponi, 2008, European psychiatry.

Aberrant salience in cannabis-induced psychosis: a comparative study

F. Vellante, M. Pettorruso, D. de Berardis, 2024, Frontiers in Psychiatry.

CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE.

D. de Berardis, F. Ceci, V. Ricci, 2023, Psychiatria Danubina.

Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review

D. de Berardis, V. Ricci, Giuseppe Maina, 2024, Healthcare.

Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation

M. Pettorruso, M. Pepe, V. Ricci, 2024, Journal of clinical medicine.

Rethinking Mental Automatism: De Clérambault’s Theory in the Age of Novel Psychoactive Drugs: Psychotropic Effects and Synthetic Psychosis

V. Ricci, G. Martinotti, Giuseppe Maina, 2024, Healthcare.

The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances

V. Ricci, Giovanni Martinotti, Giuseppe Maina, 2024, Psychopathology.

Brain-derived neurotrophic factor and electroconvulsive therapy in a schizoaffective patient with treatment-resistant paranoid-hallucinatory symptoms

C. Caltagirone, P. Bria, G. Martinotti, 2011, European Psychiatry.

Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel

A. Carano, P. De Fazio, M. Di Nicola, 2023, Annals of General Psychiatry.